Robyn Karnauskas

Stock Analyst at Truist Securities

(0.94)
# 2213
Out of 5,370 analysts
216
Total ratings
37.98%
Success rate
-4.07%
Average return
44 Stocks
Name Action PT Current % Upside Ratings Updated
ABCL AbCellera Biologics
Maintains: Buy
28 10
3.16 216.46% 2 May 16, 2025
AMGN Amgen
Maintains: Hold
333 298
295.12 0.98% 12 Jan 8, 2025
BMY Bristol-Myers Squibb
Maintains: Strong Buy
62 65
48.55 33.88% 2 Jan 8, 2025
MRK Merck & Co
Downgrades: Hold
130 110
80.88 36% 11 Jan 8, 2025
GILD Gilead Sciences
Maintains: Hold
82 83
110.72 -25.04% 15 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
195 210
190.7 10.12% 8 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Jun 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
340 340
131.07 159.4% 17 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
26 26
2.52 931.75% 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 7
0.78 797.44% 13 May 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
1135 1135
522.29 117.31% 16 Apr 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10
1.75 471.43% 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
2.81 220.28% 4 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
74
18.96 290.3% 2 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
23
11.07 107.77% 5 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
48
15.48 210.08% 5 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50
9.08 450.66% 8 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
850
807.13 5.31% 4 Mar 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
456 508
450.66 12.72% 12 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 36
24.39 47.6% 5 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
29
n/a n/a 1 Oct 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
25
51.79 -51.73% 1 Oct 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 6 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
140
56.19 149.15% 5 Sep 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
150
n/a n/a 2 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
7
1.23 469.11% 3 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
65 55
15.11 264% 1 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Dec 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
500 320
32.53 883.71% 2 Aug 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 15
3.77 297.88% 5 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 4
n/a n/a 2 Mar 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
65 10
n/a n/a 5 Nov 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
32
n/a n/a 4 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
580 120
n/a n/a 1 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
n/a n/a 1 Nov 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
85
n/a n/a 1 Oct 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
180 165
n/a n/a 5 May 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
100 77
n/a n/a 6 Dec 17, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 44
n/a n/a 3 Aug 20, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
44 63
n/a n/a 3 Mar 1, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 3 Feb 16, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 18, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
62 87
n/a n/a 1 Mar 2, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
6 8
n/a n/a 1 Mar 3, 2016